Loading…

A Guide to IL‐1 family cytokines in adjuvanticity

Growing awareness of the multiplicity of roles for the IL‐1 family in immune regulation has prompted research exploring these cytokines in the context of vaccine‐induced immunity. While tightly regulated, cytokines of the IL‐1 family are normally released in response to cellular stress and in combin...

Full description

Saved in:
Bibliographic Details
Published in:The FEBS journal 2018-07, Vol.285 (13), p.2377-2401
Main Authors: Muñoz‐Wolf, Natalia, Lavelle, Ed C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393
cites cdi_FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393
container_end_page 2401
container_issue 13
container_start_page 2377
container_title The FEBS journal
container_volume 285
creator Muñoz‐Wolf, Natalia
Lavelle, Ed C.
description Growing awareness of the multiplicity of roles for the IL‐1 family in immune regulation has prompted research exploring these cytokines in the context of vaccine‐induced immunity. While tightly regulated, cytokines of the IL‐1 family are normally released in response to cellular stress and in combination with other danger‐/damage‐associated molecular patterns (DAMPs), triggering potent local and systemic immune responses. In the context of infection or autoimmunity, engagement of IL‐1 family receptors links robust innate responses to adaptive immunity. Clinical and experimental evidence has revealed that many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members in response to adjuvant‐induced damage or cell death may be a determining factor in the transition from local inflammation to the induction of an adaptive response. Here, we analyse the effects of IL‐1 family cytokines on innate and adaptive immunity with a particular emphasis on activation of antigen‐presenting cells and induction of T cell‐mediated immunity, and we address in detail the contribution of these cytokines to the modes of action of vaccine adjuvants including those currently approved for human use. Many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members and damage‐/danger‐associated molecular patterns (DAMPs) induced by the adjuvant may act as a decisive factor in the transition from local inflammation to the induction of adaptive responses. This review explores the role of IL‐1 family cytokines in the mode of action of adjuvants in clinical and preclinical use.
doi_str_mv 10.1111/febs.14467
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2025796500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2025796500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393</originalsourceid><addsrcrecordid>eNp9kMtKw0AUhgdRbK1ufAAJuBEhdSaZ67KWthYKLlRwN0wmE5iaS80kSnY-gs_okzg1tQsXns05i4-f838AnCM4Rn5uMpO4McKYsgMwRAxHIaaEH-5v_DwAJ86tIYwJFuIYDCJBCSWYDkE8CRatTU3QVMFy9fXxiYJMFTbvAt011YstjQtsGah03b6psrHaNt0pOMpU7szZbo_A03z2OL0LV_eL5XSyCjUmgoUmSgRPWKqxUIJDZYTBOlaIQs5TpLOMY41YEnPCMsIoJYlGnMYpFFxrEYt4BK763E1dvbbGNbKwTps8V6WpWicjGBHmm_heI3D5B11XbV367zxFacyhL-yp657SdeVcbTK5qW2h6k4iKLcq5Val_FHp4YtdZJsUJt2jv-48gHrg3eam-ydKzme3D33oN7OFfIk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2066380656</pqid></control><display><type>article</type><title>A Guide to IL‐1 family cytokines in adjuvanticity</title><source>Full-Text Journals in Chemistry (Open access)</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Muñoz‐Wolf, Natalia ; Lavelle, Ed C.</creator><creatorcontrib>Muñoz‐Wolf, Natalia ; Lavelle, Ed C.</creatorcontrib><description>Growing awareness of the multiplicity of roles for the IL‐1 family in immune regulation has prompted research exploring these cytokines in the context of vaccine‐induced immunity. While tightly regulated, cytokines of the IL‐1 family are normally released in response to cellular stress and in combination with other danger‐/damage‐associated molecular patterns (DAMPs), triggering potent local and systemic immune responses. In the context of infection or autoimmunity, engagement of IL‐1 family receptors links robust innate responses to adaptive immunity. Clinical and experimental evidence has revealed that many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members in response to adjuvant‐induced damage or cell death may be a determining factor in the transition from local inflammation to the induction of an adaptive response. Here, we analyse the effects of IL‐1 family cytokines on innate and adaptive immunity with a particular emphasis on activation of antigen‐presenting cells and induction of T cell‐mediated immunity, and we address in detail the contribution of these cytokines to the modes of action of vaccine adjuvants including those currently approved for human use. Many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members and damage‐/danger‐associated molecular patterns (DAMPs) induced by the adjuvant may act as a decisive factor in the transition from local inflammation to the induction of adaptive responses. This review explores the role of IL‐1 family cytokines in the mode of action of adjuvants in clinical and preclinical use.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.14467</identifier><identifier>PMID: 29656546</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adaptive immunity ; Adjuvanticity ; Adjuvants ; Antigen-presenting cells ; Autoimmunity ; Cell activation ; Cell death ; Cellular stress response ; cell‐mediated immunity ; Cytokines ; Damage patterns ; Hazards ; Immune response ; Immunity ; Immunoregulation ; inflammasome ; interleukin‐1 family ; Lymphocytes ; Lymphocytes T ; Molecular chains ; NLRP3 ; Receptors ; vaccine ; Vaccines</subject><ispartof>The FEBS journal, 2018-07, Vol.285 (13), p.2377-2401</ispartof><rights>2018 Federation of European Biochemical Societies</rights><rights>2018 Federation of European Biochemical Societies.</rights><rights>Copyright © 2018 Federation of European Biochemical Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393</citedby><cites>FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29656546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muñoz‐Wolf, Natalia</creatorcontrib><creatorcontrib>Lavelle, Ed C.</creatorcontrib><title>A Guide to IL‐1 family cytokines in adjuvanticity</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Growing awareness of the multiplicity of roles for the IL‐1 family in immune regulation has prompted research exploring these cytokines in the context of vaccine‐induced immunity. While tightly regulated, cytokines of the IL‐1 family are normally released in response to cellular stress and in combination with other danger‐/damage‐associated molecular patterns (DAMPs), triggering potent local and systemic immune responses. In the context of infection or autoimmunity, engagement of IL‐1 family receptors links robust innate responses to adaptive immunity. Clinical and experimental evidence has revealed that many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members in response to adjuvant‐induced damage or cell death may be a determining factor in the transition from local inflammation to the induction of an adaptive response. Here, we analyse the effects of IL‐1 family cytokines on innate and adaptive immunity with a particular emphasis on activation of antigen‐presenting cells and induction of T cell‐mediated immunity, and we address in detail the contribution of these cytokines to the modes of action of vaccine adjuvants including those currently approved for human use. Many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members and damage‐/danger‐associated molecular patterns (DAMPs) induced by the adjuvant may act as a decisive factor in the transition from local inflammation to the induction of adaptive responses. This review explores the role of IL‐1 family cytokines in the mode of action of adjuvants in clinical and preclinical use.</description><subject>Adaptive immunity</subject><subject>Adjuvanticity</subject><subject>Adjuvants</subject><subject>Antigen-presenting cells</subject><subject>Autoimmunity</subject><subject>Cell activation</subject><subject>Cell death</subject><subject>Cellular stress response</subject><subject>cell‐mediated immunity</subject><subject>Cytokines</subject><subject>Damage patterns</subject><subject>Hazards</subject><subject>Immune response</subject><subject>Immunity</subject><subject>Immunoregulation</subject><subject>inflammasome</subject><subject>interleukin‐1 family</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Molecular chains</subject><subject>NLRP3</subject><subject>Receptors</subject><subject>vaccine</subject><subject>Vaccines</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKw0AUhgdRbK1ufAAJuBEhdSaZ67KWthYKLlRwN0wmE5iaS80kSnY-gs_okzg1tQsXns05i4-f838AnCM4Rn5uMpO4McKYsgMwRAxHIaaEH-5v_DwAJ86tIYwJFuIYDCJBCSWYDkE8CRatTU3QVMFy9fXxiYJMFTbvAt011YstjQtsGah03b6psrHaNt0pOMpU7szZbo_A03z2OL0LV_eL5XSyCjUmgoUmSgRPWKqxUIJDZYTBOlaIQs5TpLOMY41YEnPCMsIoJYlGnMYpFFxrEYt4BK763E1dvbbGNbKwTps8V6WpWicjGBHmm_heI3D5B11XbV367zxFacyhL-yp657SdeVcbTK5qW2h6k4iKLcq5Val_FHp4YtdZJsUJt2jv-48gHrg3eam-ydKzme3D33oN7OFfIk</recordid><startdate>201807</startdate><enddate>201807</enddate><creator>Muñoz‐Wolf, Natalia</creator><creator>Lavelle, Ed C.</creator><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201807</creationdate><title>A Guide to IL‐1 family cytokines in adjuvanticity</title><author>Muñoz‐Wolf, Natalia ; Lavelle, Ed C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adaptive immunity</topic><topic>Adjuvanticity</topic><topic>Adjuvants</topic><topic>Antigen-presenting cells</topic><topic>Autoimmunity</topic><topic>Cell activation</topic><topic>Cell death</topic><topic>Cellular stress response</topic><topic>cell‐mediated immunity</topic><topic>Cytokines</topic><topic>Damage patterns</topic><topic>Hazards</topic><topic>Immune response</topic><topic>Immunity</topic><topic>Immunoregulation</topic><topic>inflammasome</topic><topic>interleukin‐1 family</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Molecular chains</topic><topic>NLRP3</topic><topic>Receptors</topic><topic>vaccine</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muñoz‐Wolf, Natalia</creatorcontrib><creatorcontrib>Lavelle, Ed C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muñoz‐Wolf, Natalia</au><au>Lavelle, Ed C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Guide to IL‐1 family cytokines in adjuvanticity</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2018-07</date><risdate>2018</risdate><volume>285</volume><issue>13</issue><spage>2377</spage><epage>2401</epage><pages>2377-2401</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Growing awareness of the multiplicity of roles for the IL‐1 family in immune regulation has prompted research exploring these cytokines in the context of vaccine‐induced immunity. While tightly regulated, cytokines of the IL‐1 family are normally released in response to cellular stress and in combination with other danger‐/damage‐associated molecular patterns (DAMPs), triggering potent local and systemic immune responses. In the context of infection or autoimmunity, engagement of IL‐1 family receptors links robust innate responses to adaptive immunity. Clinical and experimental evidence has revealed that many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members in response to adjuvant‐induced damage or cell death may be a determining factor in the transition from local inflammation to the induction of an adaptive response. Here, we analyse the effects of IL‐1 family cytokines on innate and adaptive immunity with a particular emphasis on activation of antigen‐presenting cells and induction of T cell‐mediated immunity, and we address in detail the contribution of these cytokines to the modes of action of vaccine adjuvants including those currently approved for human use. Many vaccine adjuvants induce the release of one or multiple IL‐1 family cytokines. The coordinated release of IL‐1 family members and damage‐/danger‐associated molecular patterns (DAMPs) induced by the adjuvant may act as a decisive factor in the transition from local inflammation to the induction of adaptive responses. This review explores the role of IL‐1 family cytokines in the mode of action of adjuvants in clinical and preclinical use.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>29656546</pmid><doi>10.1111/febs.14467</doi><tpages>25</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-464X
ispartof The FEBS journal, 2018-07, Vol.285 (13), p.2377-2401
issn 1742-464X
1742-4658
language eng
recordid cdi_proquest_miscellaneous_2025796500
source Full-Text Journals in Chemistry (Open access); Wiley-Blackwell Read & Publish Collection
subjects Adaptive immunity
Adjuvanticity
Adjuvants
Antigen-presenting cells
Autoimmunity
Cell activation
Cell death
Cellular stress response
cell‐mediated immunity
Cytokines
Damage patterns
Hazards
Immune response
Immunity
Immunoregulation
inflammasome
interleukin‐1 family
Lymphocytes
Lymphocytes T
Molecular chains
NLRP3
Receptors
vaccine
Vaccines
title A Guide to IL‐1 family cytokines in adjuvanticity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T20%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Guide%20to%20IL%E2%80%901%20family%20cytokines%20in%20adjuvanticity&rft.jtitle=The%20FEBS%20journal&rft.au=Mu%C3%B1oz%E2%80%90Wolf,%20Natalia&rft.date=2018-07&rft.volume=285&rft.issue=13&rft.spage=2377&rft.epage=2401&rft.pages=2377-2401&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.14467&rft_dat=%3Cproquest_cross%3E2025796500%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4597-e2b98b7dc49a980ae9e4c3a16088d1cff84c17b3857f57665bc1863d098cc9393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2066380656&rft_id=info:pmid/29656546&rfr_iscdi=true